🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
VG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Inject...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital，Zhejiang University School of Medicine
Start Date
2026-07-01
Trial ID
NCT07522476
Treatments Being Tested
An open-label, multicenter, phase Ib/II study of AK112 in combination with ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine，No. 79, Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province
Start Date
2026-03-02
Trial ID
NCT07357220
This is a Phase 1, open-label, dose-escalation trial using standard 3+3 dos...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2022-11-09
Trial ID
NCT05266612
Treatments Being Tested
VG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Inject...
Status
Recruiting
Location
The First Affiliated Hospital，Zhejiang University School of Medicine
Start Date
2022-08-23
Trial ID
NCT05477849
Treatments Being Tested
VG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Inject...
Status
Not Yet Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2026-09-04
Trial ID
NCT07682870
Treatments Being Tested
To find the recommended dose of the investigational drug VG2025 that can be...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2024-09-30
Trial ID
NCT06365918
Treatments Being Tested